Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants

Bernard Vanhove; Stéphane Marot; Ray T So; Benjamin Gaborit; Gwénaëlle Evanno; Isabelle Malet; Guillaume Lafrogne; Edwige Mevel; Carine Ciron; Pierre-Joseph Royer; Elsa Lheriteau; François Raffi; Roberto Bruzzone; Chris Ka Pun Mok; Odile Duvaux; Anne-Geneviève Marcelin; Vincent Calvez

doi:10.3389/fimmu.2023.1208705

Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants

Front Immunol. 2023 Apr 28:14:1208705. doi: 10.3389/fimmu.2023.1208705. eCollection 2023.

Authors

Bernard Vanhove¹, Stéphane Marot², Ray T So³, Benjamin Gaborit^{4

5}, Gwénaëlle Evanno¹, Isabelle Malet², Guillaume Lafrogne¹, Edwige Mevel¹, Carine Ciron¹, Pierre-Joseph Royer¹, Elsa Lheriteau¹, François Raffi^{4

5}, Roberto Bruzzone^{3

6}, Chris Ka Pun Mok^{7

8}, Odile Duvaux¹, Anne-Geneviève Marcelin², Vincent Calvez²

Affiliations

¹ Xenothera, Nantes, France.
² Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM) 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France.
³ Hong Kong University (HKU)-Pasteur Research Pole, School of Public Health, Li Ka Shing (LKS) Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.
⁴ Department of Infectious Disease, Nantes University Hospital, Nantes, France.
⁵ Institut National de la Santé et de la Recherche Médicale (INSERM) CIC1413, Nantes University Hospital, Nantes, France.
⁶ Department of Cell Biology and Infection, Institut Pasteur, Paris, France.
⁷ Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.
⁸ The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2021.761250.].

Keywords: COVID-19; SARS-CoV-2; neutralization; polyclonal antibody (PAb); variants.

Publication types

Published Erratum

Grants and funding

This work was supported by Xenothera, the European Union’s Horizon 2020 research and innovation programme (grant agreement No 962036), the Agence Nationale de la Recherche sur le SIDA et les Maladies Infectieuses Emergentes (ANRS MIE), AC43 Medical Virology and Emergen Program, the SARS-CoV-2 Program of the Faculty of Medicine of Sorbonne Université and by Bpifrance, grant «Projet de Recherche et Développement Structurant Pour la Compétitivité spécifique à la crise sanitaire COVID-19—POLYCOR» and the National Research Foundation of Korea (NRF) grant funded through the Korea government (NRF-2018M3A9H4055203).